Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae134 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Tram Kim Lam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: Obesity, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
With the escalating prevalence of obesity, the association between obesity and cancer is a growing public health concern. Obesity will soon surpass tobacco smoking as the most important preventable cause of cancer. Obesity-driven mechanisms can alter cell functions to induce metabolic changes, chronic inflammation, and insulin resistance that are believed to contribute to cancer risk and development; yet the specific underlying biological mechanisms of obesity-related cancer development are largely unknown. The Metabolic Dysregulation and Cancer Risk Program: a transdisciplinary approach to obesity-associated cancers (MeDOC) is a trans–National Cancer Institute research initiative supported by the Division of Cancer Control and Population Sciences, the Division of Cancer Biology, the Division of Cancer Prevention, and the Center to Reduce Cancer Health Disparities. The overall purpose of the MeDOC Program is to advance our understanding of the underlying mechanisms that connect obesity, metabolic dysregulation, and increased obesity cancer risk as well as identify markers that will enhance cancer risk prediction, improve screening for high-risk individuals, and identify targets for preventive and therapeutic interventions for cancer interception or treatment. This report describes the funded research projects, the Coordinating Center, and the goals of the MeDOC program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
- Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
- Center to Reduce Cancer Health Disparities, National Cancer Institute, Rockville, MD, USA.
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
ORCID-Profile: Tram Kim Lam
Förderung
- NCI
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Lam, T. K., Daschner, P., Ishibe, N., Wali, A., Hall, K., Czajkowski, S., Mahabir, S., Watson, J. M., Nebeling, L., Ross, S., & Sauter, E. (2024). Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae134
Vancouver
Lam TK, Daschner P, Ishibe N, Wali A, Hall K, Czajkowski S, et al. Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae134
BibTeX
@article{Lam2024,
author = {Lam, Tram Kim and Daschner, Phil and Ishibe, Naoko and Wali, Anil and Hall, Kara and Czajkowski, Susan and Mahabir, Somdat and Watson, Joanna M and Nebeling, Linda and Ross, Sharon and Sauter, Edward},
title = {Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae134}
}
EUVIMED